71 related articles for article (PubMed ID: 11449838)
1. How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet.
Béné MC; Kaeda JS
Haematologica; 2009 Aug; 94(8):1135-50. PubMed ID: 19586938
[TBL] [Abstract][Full Text] [Related]
2. An ultra-rapid screening method for acute leukemias.
Axler O; Bild F; Johansson ÅCM
Cytometry B Clin Cytom; 2023 Nov; 104(6):474-477. PubMed ID: 37555457
[No Abstract] [Full Text] [Related]
3. [Detection of BCR-ABL gene sequences using RT-PCR in patients with leukemia in the IX region. Chile].
Artigas CG; Melo A; Roa JC; Páez E; Vittini C; Arriagada M; González L; Pflaumer E; Roa I
Rev Med Chil; 2002 Jun; 130(6):623-30. PubMed ID: 12194684
[TBL] [Abstract][Full Text] [Related]
4. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
[TBL] [Abstract][Full Text] [Related]
5. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of WT-1 and Bcr-Abl measured by TaqMan quantitative real-time RT-PCR during follow-up of leukemia patients with the Ph chromosome.
Chen ZX; Kaeda J; Saunders S; Goldman JM
Chin Med J (Engl); 2004 Jul; 117(7):968-71. PubMed ID: 15265366
[TBL] [Abstract][Full Text] [Related]
8. [Role of molecular genetic investigations in the diagnosis of acute leukemias and in the detection of minimal residual disease].
Földi J; Páldi HP; Nahajevszky S; Jakab K; Regéczi N; Pálóczi K
Orv Hetil; 2001 May; 142(21):1097-102. PubMed ID: 11449838
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease detection in human leukemias: biologic and clinical significance.
Saglio G
Acta Haematol Pol; 1995; 26(2 Suppl 1):19-24. PubMed ID: 7653231
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic pathways in acute leukemias: a proposal for a multimodal approach.
Haferlach T; Bacher U; Kern W; Schnittger S; Haferlach C
Ann Hematol; 2007 May; 86(5):311-27. PubMed ID: 17375301
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and classification of the acute leukemias: recent advances and controversial issues.
Taylor CG; Stasi R; Bastianelli C; Venditti A; Del Poeta G; Amadori S; Sargent J
Hematopathol Mol Hematol; 1996; 10(1-2):1-38. PubMed ID: 8792146
[TBL] [Abstract][Full Text] [Related]
12. Implications of detection of minimal residual disease.
Wörmann B
Curr Opin Oncol; 1993 Jan; 5(1):3-12. PubMed ID: 8427891
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]